
Sign up to save your podcasts
Or


In this episode, Professor Rory O’Connor and Craig spoke to Edmond J. Safra Professor of Neuropsychopharmacology and the head of the Psychedelics Research Centre at Imperial College London, Professor David Nutt.
David specialises in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Currently, David is investigating if psychedelic drugs can be effective against treatment-resistant depression.
In this conversation, they discussed the stigma around drugs, alternative treatments for mental health issues, and why openness is important in research and innovation.
By MQ Mental Health Research4
22 ratings
In this episode, Professor Rory O’Connor and Craig spoke to Edmond J. Safra Professor of Neuropsychopharmacology and the head of the Psychedelics Research Centre at Imperial College London, Professor David Nutt.
David specialises in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Currently, David is investigating if psychedelic drugs can be effective against treatment-resistant depression.
In this conversation, they discussed the stigma around drugs, alternative treatments for mental health issues, and why openness is important in research and innovation.

93 Listeners

62 Listeners

2,528 Listeners

745 Listeners

99,698 Listeners

684 Listeners

68 Listeners

3,858 Listeners

2,131 Listeners

105 Listeners

43 Listeners